FPHAX Mutual Fund

NAV$34.87

AUM$703M

TER0.67%

Holdings60

See how much of FPHAX you already own

Just $25 once·$99/mo·Download sample

X-ray my portfolio free

FPHAX Mutual Fund

NAV$34.87

Fidelity Select Pharmaceuticals Portfolio

AUM$703M

TER0.67%

Holdings60

See how much of FPHAX you already own

Just $25 once·$99/mo·Download sample

X-ray my portfolio free

Overview Performance Chart Dividends Top Holdings All Holdings Sectors Geography Similar Compare Overlap

Showing top 50 of 60 holdings · as of Feb 28, 2026

FPHAX holdings, by weight
#	Ticker	Name	Weight	Cumulative	Shares	Mkt value	Share chg	Sector	Industry
1	LLY	Eli Lilly & Co.Health Care · Pharmaceuticals	25.18%	25.2%	362,801	$381.66M	+38.9K	Health Care	Pharmaceuticals
2	—	Gsk Plc Sponsored Adr (1 Ads : 2 Ordinary)Health Care · Pharmaceuticals	10.07%	35.3%	2,581,360	$152.64M	+1.21M	Health Care	Pharmaceuticals
Share changes, sector and industry · Pro
3	JNJ	Johnson & Johnson -	7.53%	42.8%	459,700	$114.20M
4	—	Ucb Sa	5.01%	47.8%	254,500	$75.87M
5	—	AstraZeneca PLC	4.93%	52.7%	358,250	$74.68M
6	—	Roche Holding AG	4.93%	57.6%	157,090	$74.76M
7	GILD	Gilead Sciences	4.64%	62.3%	472,500	$70.38M
8	MRK	Merck & Company Inc	4.59%	66.9%	561,536	$69.53M
9	ELAN	Elanco Animal Health, Inc Cvr	4.42%	71.3%	2,536,200	$66.96M
10	NMF	Fidelity Securities Lending Cash Central Fund	4.26%	75.6%	64,528,910	$64.54M
11	LEGN	Legend Biotech Corp-adr	3.26%	78.8%	2,598,400	$49.37M
12	JAZZ	Jazz Pharmaceuticals Plc.	2.85%	81.7%	227,700	$43.27M
13	—	Moderna therapeutics	2.43%	84.1%	688,800	$36.90M
14	RPRX	Royalty Pharma	2.29%	86.4%	750,500	$34.68M
15	VTRS	Viatris Inc.	1.70%	88.1%	1,729,600	$25.82M
16	TUB	Financiere De Tubize Sa	1.62%	89.7%	91,587	$24.51M
17	—	Biontech Se Adr	0.96%	90.7%	132,653	$14.62M
18	MRCG	Merck Kgaa	0.95%	91.6%	94,700	$14.35M
19	—	Biogen Inc 3.625 9/22	0.92%	92.5%	73,000	$14.00M
20	OCUL	Ocular Therapeutix Inc	0.79%	93.3%	1,331,717	$11.91M
21	BEAM	Beam Therapeutics Inc.	0.78%	94.1%	415,400	$11.82M
22	—	Xenon Pharmaceuticals Inc. Common Shares	0.77%	94.9%	268,600	$11.61M
23	—	Uniqure N.V. Ordinary Shares	0.73%	95.6%	705,578	$11.03M
24	CAPR	Capricor Therapeutics Inc	0.72%	96.3%	389,900	$10.89M
25	PTCT	Ptc Therapeutics Inc	0.70%	97.0%	155,600	$10.61M
26	KYMR	Kymera Therapeutics Inc	0.61%	97.6%	102,000	$9.32M
27	PAHC	Phibro Animal Health Corp	0.54%	98.2%	150,755	$8.23M
28	AXSM	Axsome Therapeutics Inc	0.53%	98.7%	48,900	$8.01M
29	ANNX	Annexon Inc	0.47%	99.2%	1,264,100	$7.08M
30	ASND	Ascendis Pharma A/S	0.38%	99.6%	24,400	$5.70M
31	CORT	Corcept Therapeutics Inc	0.37%	99.9%	158,100	$5.64M
32	NTLA	Intellia Therapeutics Inc	0.35%	100.3%	384,500	$5.30M
33	—	Agomab Therapeutics Sa (180 Day Lock-Up)	0.35%	100.6%	332,858	$5.33M
34	CRNX	Crinetics Pharmaceuticals Inc	0.33%	101.0%	122,800	$5.05M
35	FTBFX	Fidelity Cash Central Fund	0.32%	101.3%	4,809,384	$4.81M
36	HRMY	Harmony Biosciences, Llc	0.30%	101.6%	158,577	$4.53M
37	ARWR	Arrowhead Pharmaceuticals Inc	0.27%	101.9%	65,400	$4.14M
38	VERA	Vera Therapeutics Inc Ser C Pc Pp	0.27%	102.1%	100,700	$4.11M
39	WVE	Wave Life Sciences Ltd	0.27%	102.4%	296,800	$4.13M
40	AMLX	Amylyx Pharmaceuticals Inc	0.26%	102.7%	257,800	$3.91M
41	IRON	Disc Medicine Inc	0.24%	102.9%	53,800	$3.58M
42	—	Definium Therapeutics, Inc. Common Shares	0.22%	103.1%	188,000	$3.28M
43	IDIA	Idorsia, Ltd.	0.21%	103.3%	639,660	$3.26M
44	SMMT	Summit Therapeutics	0.19%	103.5%	169,304	$2.81M
45	EWTX	Edgewise Therapeutics Inc.	0.17%	103.7%	83,600	$2.54M
46	AVBP	Arrivent Biopharma Inc	0.16%	103.8%	107,000	$2.46M
47	VKTX	Viking Therapeutics Inc	0.14%	104.0%	64,300	$2.18M
48	—	Paragon Biosciences Emalex Capital Inc Ser C Pc Pp	0.10%	104.1%	158,879	$1.48M
49	—	Castle Creek Biosciences Inc Ser D-1 Pc Pp	0.09%	104.2%	6,308	$1.42M
50	Debt	Evozyne Inc Cpik	0.08%	104.2%	-	$1.19M
More holdings · Pro

FundXLS Pro

See the other 10 holdings of FPHAX

X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.

Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

FPHAX Mutual Fund All Holdings

FPHAX holdings total 60 positions. The top 10 holdings account for 75.6% of the fund, led by Eli Lilly & Co. at 25.2%, Gsk Plc Sponsored Adr (1 Ads : 2 Ordinary) at 10.1%, Johnson & Johnson - Common at 7.5%.

FPHAX portfolio concentration is relatively high, with the top 10 representing 75.6% of total assets. The largest sector exposure is Health Care at 82.6%.

FPHAX sectors provide a detailed breakdown. FPHAX overlap shows how holdings compare to other funds in your portfolio.